title: Mother-to-child transmission. How will AZT and nevirapine use for MTCT affect future treatment? Two studies provide clues.
authors.forename: Theo
authors.initials: T
authors.lastname: Smart
mesh_terms: D018791:CD4 Lymphocyte Count; D005260:Female; D015658:HIV Infections / Q000635:transmission*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D019829:Nevirapine / Q000008:administration & dosage*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D019562:Viral Load; D015215:Zidovudine / Q000008:administration & dosage*
chemical_list: D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D019829:Nevirapine